These results provide strong evidence that Kir6.2-Q52R interacts with SUR1-W51 to enhance channel activity and reduce ATP inhibition, thus providing an explanation for the SUR1-dependent pathophysiology of this neonatal diabetes mutation. Here, KCNJ11 is linked to diabetes mellitus.